CAIHL read · Jun 12, 2026
STAT+: Abridge inks deals with Nvidia and Lilly
Framework
What CAIHL does
Critical AI Health Literacy (CAIHL) is an analytical lens — Hugo Campos and Liz Salmi's 2025 National Academy of Medicine commentary, "Critical AI Health Literacy as Liberation Technology." It applies Paulo Freire's theory of critical literacy to health AI.
The central question CAIHL asks is whose interests does this AI actually serve? Four dimensions answer it: who is the primary user, where is it hosted, whose interests does it advance, and does it expand or constrain patient agency.
This deep-read separates the four dimensions on a single item from the day's scan, so you can see the specific structural shape of the AI in question — not just the bucket it landed in.
The four dimensions
How this item reads through CAIHL
Primary user
clinician
Clinicians or care teams are the primary users. Patients are affected downstream.
Hosting
institutional
Hosted inside a health system, insurer, or large employer. Access controlled by the institution.
Interests
commercial
Prioritizes vendor or platform commercial interests (advertising, data, retention).
Agency
constraining
Channels patients toward predetermined pathways or substitutes for patient capabilities.
Editor's CAIHL read
One-sentence synthesis
Ambient-scribe vendor expanding downstream uses for the recorded consultation; constraining patient agency through scope creep beyond the original consent.
In the scan
How this item appeared in the daily scan
Editor's note: When the ambient-scribe vendor expands into payer and research workflows, the same recorded patient consultation is now monetized across three downstream parties. The consent envelope the patient signed at the chair was not for that distribution.
Summary: STAT: Abridge — the leading clinical ambient-scribe vendor — inks strategic deals with Nvidia and Eli Lilly, expanding from documentation workflow into payer and research surfaces.
methodology
Limitations
CAIHL is a lens, not a verdict. The four dimensions are conditions of use — reassess them when a tool's business model, deployment context, or patient behavior changes. See the NAM commentary for the full framework.